Skip to search formSkip to main contentSkip to account menu

frovatriptan

Known as: 3-methylamino-6-carboxamido-1,2,3,4-tetrahydrocarbazole, frovatriptan [Chemical/Ingredient] 
National Institutes of Health

Related topics

Related topics

19 relations

Narrower (4)

AllegroFrovaSB 209509VML-251
Angina Pectoris, VariantCerebral Arterial Vasoconstriction [PE]Cerebrovascular accidentDrug Allergy

Broader (3)

CarbazolesSerotonin AgonistsTryptamines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Sublingual Delivery of Frovatriptan: An Indication of Potential Alternative Route
Frovatriptan, a 5-HT1B and 5-HT1D receptor agonist, is used for the treatment of acute migraine attack. This molecule is… 
2014
2014
Efficacy and pharmacokinetic activity of frovatriptan compared to rizatriptan in patients with moderate-to-severe migraine
Background Migraine is a painful neurological disorder that affects over 10% of the general population. Frovatriptan and… 
Review
2011
Review
2011
Pharmacokinetic evaluation of frovatriptan
Introduction: Migraine is the most common painful neurological disorder, affecting 13% of the general population. Triptans… 
Review
2011
Review
2011
Handbook of Headache
The text presents a systematic approach to diagnosis, and is rich with expert recommendations for treating all types of headaches… 
2010
2010
Treatment response and tolerability of frovatriptan in patients reporting short- or long-duration migraines at baseline
Abstract Objectives: Compare migraine duration with frovatriptan (versus baseline) in migraineurs reporting long- (24−72 h) or… 
2009
2009
Rapid responders to frovatriptan in acute migraine treatment: results from a long-term, open-label study.
BACKGROUND The chronic nature of migraine and the reliance on acute treatment constitute the basis of the present long-term, open… 
Review
2005
Review
2005
Efficacy and tolerability of frovatriptan in acute migraine treatment: systematic review of randomized controlled trials
Objective:  To evaluate the efficacy and tolerability of frovatriptan in acute migraine treatment. 
Review
2001
Review
2001
Comparative aspects of triptans in treating migraine.
2001
2001
Comparative effects of frovatriptan and sumatriptan on coronary and internal carotid vascular haemodynamics in conscious dogs
The effects of frovatriptan and sumatriptan on internal carotid and coronary vascular haemodynamics were investigated and… 
1998
1998
Effects of the novel antimigraine agent, frovatriptan, on coronary and cardiac function in dogs.
The effects of frovatriptan (VML 251/SB-209509) on coronary artery function were investigated in isolated coronary arteries from… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)